Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
How would you approach management of bleeding risk and factor VIII replacement in a patient with severe hemophilia A undergoing stem cell transplant?
Answer from: at Academic Institution
Same way as anyone with severe hemophilia: Prophy with QOD factor or weekly hemlibra Extra correction for procedures, trauma, or bleeding
Comments
at Ann & Robert H. Lurie Children’s Hospital of Chicago
Thank you Dr. @Gary Kupfer! Would you have any con...
at Georgetown University Hospital
Good point. I wouldn’t say it is studied...
7770
7773
Sign in or Register to read more
15541
Related Questions
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Which classes of medications are reasonable to consider in cases of acute pericarditis in a patient with G6PD deficiency?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
In pure red cell aplasia, does peripheral blood-positive IgG for parvovirus have significance if persistently positive on retesting, but IgM and PCR are negative?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
What experience have you had with familial clustering of polycythemia vera?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Thank you Dr. @Gary Kupfer! Would you have any con...
Good point. I wouldn’t say it is studied...